Skip to content

Clinical trials

Terminated Phase 1 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Status: Terminated Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20042
20052
20064
20076
20085
20095
20101
20128
20132
20141
20154
20169
20173
20182
20198
202011
20216
20225
20235
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins7
National Cancer Institute (NCI)6
Novartis Pharmaceuticals3
Pfizer3
University of Michigan Rogel Cancer Center3
Agennix2
Amgen2
AvenCell Europe GmbH2
Emory University2
Johns Hopkins University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms96
Breast Neoplasms15
Neoplasms7
Ovarian Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms6
Neoplasm Metastasis6
Pancreatic Neoplasms6
Carcinoma, Renal Cell5
Sarcoma5

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.